R0044/2026-04-01/Q001/SRC04

Research	R0044 — Expanded Vocabulary Research
Run	2026-04-01
Query	Q001
Search	S03
Result	S03-R01
Source	SRC04

FDA Clinical Decision Support Guidance — Automation Bias Updates (January 2026)

Source

Field	Value
Title	Automation Bias and Clinical Practice: FDA Makes Incremental Updates to Clinical Decision Support Software Guidance
Publisher	Cooley LLP (legal analysis of FDA guidance)
Author(s)	Cooley LLP
Date	January 20, 2026
URL	https://www.cooley.com/news/insight/2026/2026-01-20-automation-bias-and-clinical-practice-fda-makes-incremental-updates-to-clinical-decision-support-software-guidance
Type	Legal analysis of government guidance

Summary

Dimension	Rating
Reliability	Medium-High
Relevance	High
Bias: Missing data	Low risk
Bias: Measurement	N/A
Bias: Selective reporting	Some concerns
Bias: Randomization	N/A — not an RCT
Bias: Protocol deviation	N/A — not an RCT
Bias: COI/Funding	Some concerns

Rationale

Dimension	Rationale
Reliability	Cooley LLP is a major law firm with healthcare regulatory expertise. Analysis is based on primary FDA guidance documents. However, it is a secondary analysis, not the primary guidance itself.
Relevance	Directly addresses FDA's treatment of automation bias in clinical decision support — the healthcare-specific intersection of this query.
Bias flags	Cooley represents healthcare technology companies, creating potential bias toward industry-favorable interpretation of FDA requirements. The analysis notes FDA "continues to support its concern about automation bias by citing only a 2004 journal article," which may reflect an industry perspective that FDA's automation bias concerns are insufficiently grounded.

Evidence Extracts

Evidence ID	Summary
SRC04-E01	FDA CDS guidance focuses on human independent review, not system-side output constraints